|
HK1053833A1
(zh)
|
2000-04-27 |
2003-11-07 |
Abbott Laboratories |
取代苯基法呢基转移酶抑制剂
|
|
US20020019527A1
(en)
|
2000-04-27 |
2002-02-14 |
Wei-Bo Wang |
Substituted phenyl farnesyltransferase inhibitors
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
KR20090090406A
(ko)
|
2000-12-18 |
2009-08-25 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
염증성 사이토카인 생산 유리 억제제
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US6806265B2
(en)
|
2002-05-16 |
2004-10-19 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
|
WO2004026264A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Genelabs Technologies, Inc. |
Novel aromatic compounds possessing antifungal or antibacterial activity
|
|
JP2009513523A
(ja)
|
2003-07-08 |
2009-04-02 |
ノバルティス アクチエンゲゼルシャフト |
ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
|
|
US20080220497A1
(en)
|
2003-12-24 |
2008-09-11 |
Flynn Daniel L |
Modulation of protein functionalities
|
|
CN1810777B
(zh)
*
|
2005-01-24 |
2010-09-29 |
上海东浩医药生物企业有限公司 |
一类治疗或预防细菌感染的化合物及其制备方法和用途
|
|
JP2009533315A
(ja)
*
|
2006-04-10 |
2009-09-17 |
ランバクシー ラボラトリーズ リミテッド |
抗菌剤
|
|
US8039502B2
(en)
*
|
2007-07-24 |
2011-10-18 |
The Ohio State University Research Foundation |
Anti-infective agents against intracellular pathogens
|
|
CA2698847A1
(en)
|
2007-09-04 |
2009-03-12 |
Biolipox Ab |
Bis-aromatic compounds useful in the treatment of inflammation
|
|
EP2231655B1
(en)
|
2007-11-13 |
2011-08-31 |
Vertex Pharmaceuticals Incorporated |
4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivatives and related compounds as modulators of ion channels for the treatment of pain
|
|
CN101910166A
(zh)
|
2007-11-13 |
2010-12-08 |
沃泰克斯药物股份有限公司 |
用作钠离子通道调节剂的杂环衍生物
|
|
WO2009091856A2
(en)
|
2008-01-18 |
2009-07-23 |
Merck & Co., Inc. |
Beta-lactamase inhibitors
|
|
JP5581219B2
(ja)
|
2008-01-25 |
2014-08-27 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用
|
|
WO2009118596A2
(en)
|
2008-03-26 |
2009-10-01 |
Glenmark Pharmaceuticals, S. A. |
Phthalimide derivatives as trpa1 modulators
|
|
EP2297097A2
(en)
|
2008-06-11 |
2011-03-23 |
Irm Llc |
Compounds and compositions useful for the treatment of malaria
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
SG10201702247SA
(en)
|
2009-01-12 |
2017-04-27 |
Aerpio Therapeutics Inc |
Methods for treating vascular leak syndrome
|
|
WO2010084402A2
(en)
|
2009-01-22 |
2010-07-29 |
Orchid Research Laboratories Ltd. |
Heterocyclic compounds as phosphodiesterase inhibitors
|
|
MY160399A
(en)
|
2009-07-06 |
2017-03-15 |
Aerpio Therapeutics Inc |
Compounds, compositions, and methods for preventing metastasis of cancer cells
|
|
US9005579B2
(en)
|
2010-01-05 |
2015-04-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
|
CA2794676A1
(en)
|
2010-03-29 |
2011-10-06 |
Piramal Enterprises Limited |
Cytokine inhibitors
|
|
RU2610091C2
(ru)
|
2011-06-17 |
2017-02-07 |
Астразенека Аб |
(2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид
|
|
CA2846107C
(en)
|
2011-09-13 |
2016-06-21 |
Wockhardt Limited |
Nitrogen containing compounds and their use
|
|
MX2014008763A
(es)
*
|
2012-01-18 |
2015-04-13 |
Cellceutix Corp |
Compuestos y metodos para tratar infecciones por candidosis y aspergillus.
|
|
WO2013123444A1
(en)
|
2012-02-17 |
2013-08-22 |
Amgen Inc. |
Sulfonyl compounds that interact with glucokinase regulatory protein
|
|
US9566310B2
(en)
|
2012-09-10 |
2017-02-14 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
US10035790B2
(en)
|
2012-10-19 |
2018-07-31 |
Exelixis, Inc. |
RORγ modulators
|
|
UA111925C2
(uk)
|
2012-12-11 |
2016-06-24 |
Федора Фармасьютікалз Інк. |
БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
|
|
WO2014144606A2
(en)
|
2013-03-15 |
2014-09-18 |
Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
US9540389B2
(en)
*
|
2013-05-03 |
2017-01-10 |
Microbiotix, Inc. |
Antimicrobial potentiators
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
AU2014268477A1
(en)
|
2013-05-24 |
2015-11-12 |
The California Institute For Biomedical Research |
Compounds for treatment of drug resistant and persistent tuberculosis
|
|
GB201310542D0
(en)
*
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
ES2901198T3
(es)
|
2013-10-08 |
2022-03-21 |
Meiji Seika Pharma Co Ltd |
Formas cristalinas de derivado de diazabiciclooctano y procedimiento de producción de las mismas
|
|
EP3105231A1
(en)
|
2014-01-21 |
2016-12-21 |
Wockhardt Limited |
A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
|
|
KR20160115946A
(ko)
|
2014-02-03 |
2016-10-06 |
욱크하르트 리미티드 |
(2s,5r)-1,6-다이아자-바이사이클로[3.2.1]옥테인-2-카보나이트릴-7-옥소-6-(설포옥시)-모노 소듐 염의 제조 공정
|
|
PT3116316T
(pt)
|
2014-03-13 |
2019-09-30 |
Assembly Biosciences Inc |
Moduladores alostéricos da proteína do núcleo da hepatite b
|
|
GB2533136A
(en)
|
2014-12-11 |
2016-06-15 |
Antabio Sas |
Compounds
|